Sequencing of the exons and exon-intron boundaries of both LAMTOR2 and LAMTOR3 revealed three SNPs to occur in a sequencing sample of 50 breast cancer patients, but no novel mutations. Here, LAMTOR2 is linked to breast carcinoma.